{
    "2018-01-29": [
        [
            {
                "time": "2018-01-29",
                "original_text": "Health Care Sector Update for 01/29/2018: ABLX,SNY,NVO,BTX,ARDM",
                "features": {
                    "keywords": [
                        "ABLX",
                        "SNY",
                        "NVO",
                        "BTX",
                        "ARDM"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "AKCA ON The Move, MNLO Makes A Mark, OBSV Looks Ahead With Hope, ARGX Soars",
                "features": {
                    "keywords": [
                        "AKCA",
                        "MNLO",
                        "OBSV",
                        "ARGX"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Sanofi Announces Second Billion-Dollar Deal In a Week, and It May Not Be Done",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "billion-dollar deal"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Sanofi Beats Out Novo Nordisk in Bid to Buy Ablynx",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Novo Nordisk",
                        "Ablynx"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Novo",
                        "Ablynx",
                        "biotech",
                        "M&A"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Could Sanofi's Ablynx Deal Spur A Biopharma Buying Spree?",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Ablynx",
                        "Biopharma"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "France's Sanofi buys biotech company Ablynx for $4.8 billion",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Ablynx",
                        "biotech"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Sanofi beats Novo to buy Ablynx for 3.9 billion euros in biotech M&A boom",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Novo",
                        "Ablynx",
                        "biotech",
                        "M&A"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "AbbVie (ABBV) Soars on Q4 Results: Key Takeaways from the Earnings Call",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Q4 Results",
                        "Earnings Call"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Sanofi Will Buy Ablynx For $4.8 Billion On Heels Of $11.6 Billion Bioverativ Deal",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Ablynx",
                        "Bioverativ"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Indexes Edge Lower: Dr. Pepper Surges, Goldman Leads Dow",
                "features": {
                    "keywords": [
                        "Indexes",
                        "Dr. Pepper",
                        "Goldman",
                        "Dow"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Sanofi's $16 Billion Splurge Leaves Novo Behind on Blood Deals",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Novo",
                        "Blood Deals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "INTERVIEW: Novo Nordisk remains on hunt for biopharma deals",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "biopharma deals"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Novo Nordisk remains on hunt for biopharma deals",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "biopharma deals"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Sanofi Leapfrogs Novo With $4.8 Billion Cash Bid for Ablynx",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Novo",
                        "Ablynx",
                        "Cash Bid"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Born From Frozen Camel Blood, Ablynx Is $4.8 Billion Prize",
                "features": {
                    "keywords": [
                        "Ablynx",
                        "Camel Blood",
                        "Prize"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}